Landscapes / Companies
Debiopharm International SA not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
3 in Phase 1
Drugs
5
in active trials · 7 in all
Trials
7 active
20 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Sep 2028Phase 1/2 trial completes | |||
| Next date | Sep 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Nov 2031Phase 1/2 trial completes | |||
| Next date | Nov 2031 · Phase 1/2 trial completes | ||||
| Also tested for | Acute Myeloid Leukemia | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Renal Impairment | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
About
- No active trial
- Radiolabelled Xevinapant, Somatuline ATG
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021